ABVC BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-7.6M | $-7.6M | $17.5K | $5.3M |
| FY2022 | $-7.4M | $-7.5M | $119.7K | $7.0M |
| FY2023 | $-4.2M | $-4.2M | $21.2K | $185.9K |
| FY2024 | $-1.8M | $-1.8M | — | $2.8M |
| FY2025 | $-3.0M | $-3.0M | — | $4.1M |